Transfection Technologies Market: Opportunities and Challenges Ahead

According to a recent industry report by market research and competitive intelligence source Fact.MR, the global Transfection Technologies Market is expected to reach US$ 2.27 billion by the end of 2033, from an estimated valuation of US$ 1.10 billion in 2023. Through the use of transfection technology, nucleic acids such as oligonucleotides, deoxyribonucleic acid (DNA), and ribonucleic acid (RNA) are inserted into cells. It is delivered using a variety of physical, chemical, and biological methods that have the ability to alter certain cell properties. Co-transfection, electroporation, cationic lipid transfection, and in-vivo transfection are among the methods. This technique is widely utilized in genomic studies including gene expression, screening, RNA interference, in vivo research, and the bioproduction of viruses and proteins.

Download Sample Copy of This Report:

https://www.factmr.com/connectus/sample?flag=Srep_id=8216

Key Takeaways from Market Study

Global demand for transfection technologies is expected to increase at a CAGR of 7.5% from 2023 to 2033.

China’s market is predicted to expand at a CAGR of 7% during the projected period.

Worldwide sales of therapeutic delivery technologies are expected to rise at a CAGR of 8% during the forecast period.

Demand for protein production systems is predicted to expand at a CAGR of 7.5% during the next 10 years.

Market Developments

Thermo Fisher Scientific, a US-based corporation well known for its reagent and other equipment supplies, completed the acquisition of Pharmaceutical Product Development (PPD), a US-based CRO, on April 15, 2021. PPD received a settlement of US$ 17.4 billion. Thermo Fisher's clinical research portfolio is strengthened by the acquisition.

April 9, 2020: The company “Celsee” was successfully acquired by California-based “Bio-Rad Laboratories”, which creates specialised technology for life science. A US-based firm “Celsee” specialises in transfection technologies. Although the financial details of the agreement were kept private, Bio-Rad said that it would benefit the company's single-cell analytic capabilities.

Get Customization on this Report for Specific Research Solutions:

https://www.factmr.com/connectus/sample?flag=RCrep_id=8216

Competitive Landscape

Some of the key players in the transfection technologies market are Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Life Technologies Corporation, Lonza Group AG, MilliporeSigma; PolyPlus Battery Company (PPBC), Promega Corporation, Qiagen NV, SignaGen Laboratories, and Thermo Fisher Scientific, Inc.

Easy introduction of DNA, RNA, siRNA, or oligonucleotides into eukaryotic cells can be accomplished quickly, simply, and repeatedly via cationic lipid transfection technologies. It permits the highly effective transfection of various cell types, such as adherent, suspension, insect, and primary cultures. Thermo Fisher Scientific, Inc. has a wider portfolio range of cationic-lipid transfection reagents.

February 3, 2022: To increase their proficiency in the design and production of unique DNA vectors, Polypus, a supplier of transfection reagents, bought e-Zyvec, a company based in France.

For instance, in March 2019, Lonza introduced CellBio Services, a broad spectrum of distinctive services tailored to the needs of research applications. These include cell-line expansion, transfection, and cell banking services.

Key Companies Profiled

Bio-Rad Laboratories, Inc.
Hoffmann-La Roche AG
Life Technologies Corporation
Lonza Group AG
MilliporeSigma
PolyPlus Battery Company (PPBC)
Promega Corporation
Qiagen NV
SignaGen Laboratories
Thermo Fisher Scientific, Inc.

Get Free Access of Complete Report: https://www.factmr.com/checkout/8216

Key Segments of Transfection Technologies Industry Research

By Application :
- Protein Production
- Therapeutic Delivery
  - Biotherapeutics
  - Electro-chemotherapy and Electro-immunotherapy
- Bio-medical Research
  - Cancer Research
  - Transgenic Models
  - Gene and Protein Expression Studies
  - Cell-based Microarrays for Drug Discovery and Development
- By Method :
  - Reagent-based Method
    - Lipid Mediated Transfection (Lipofection)
    - Calcium Phosphate
    - DEAE-dextran
    - Catonic Polymers
    - Activated Dendrimers
    - Magnetic Beads
  - Instrument-based Method
    - Electroporation
    - Microinjection
    - Laserfection
    - Biolistic technology
  - Virus-based Method
- By Technology :
  - Physical Transfection
  - Biochemical-based Transfection
  - Viral-vector-based Transfection
- By End User :
  - Pharmaceutical Biotechnology Companies
  - Contract Research Organizations
  - Academic Research Institutes
  - Hospitals
- By Region :
  - North America
  - Latin America
  - Europe
  - East Asia
  - South Asia Oceania
  - MEA